The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
Open accessAbstract
BACKGROUND: Dose equivalents of antipsychotics are an important but difficult to define concept, because all methods have weaknesses and strongholds. METHODS: We calculated dose equivalents based on defined daily doses (DDDs) presented by the World Health Organisation's Collaborative Center for Drug Statistics Methodology. Doses equivalent to 1mg olanzapine, 1mg risperidone, 1mg haloperidol, and 100mg chlorpromazine were presented and compared with the results of 3 other methods to define dose equivalence (the "minimum effective dose method," the "classical mean dose method," and an international consensus statement). RESULTS: We presented dose equivalents for 57 first-generation and second-generation antipsychotic drugs, available as oral, parenteral, or depot formulations. Overall, the identified equivalent doses were comparable with those of the other methods, but there were also outliers. CONCLUSIONS: The major strength of this method to define dose response is that DDDs are available for most drugs, including old antipsychotics, that they are based on a variety of sources, and that DDDs are an internationally accepted measure. The major limitations are that the information used to estimate DDDS is likely to differ between the drugs. Moreover, this information is not publicly available, so that it cannot be reviewed. The WHO stresses that DDDs are mainly a standardized measure of drug consumption, and their use as a measure of dose equivalence can therefore be misleading. We, therefore, recommend that if alternative, more "scientific" dose equivalence methods are available for a drug they should be preferred to DDDs. Moreover, our summary can be a useful resource for pharmacovigilance studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,050
International Consensus Study of Antipsychotic Dosing
Gardner, D. M., Murphy, A. L., O'Donnell, H., Centorrino, F., & Baldessarini, R. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060802 · Cited by 1,301
Bland, J. M., & Altman, D. G. (1990) · Computers in Biology and Medicine · doi:10.1016/0010-4825(90)90013-f · Cited by 691
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini, R. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250095013 · Cited by 545
Comparative Doses and Costs of Antipsychotic Medication
Davis, J. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770070088010 · Cited by 407
Self-citationDose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Leucht, S., Samara, M., Heres, S., Patel, M. X., Woods, S. W., & Davis, J. M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu001 · Cited by 372
Self-citationDose equivalence of the anti-psychotic drugs
Davis, J. M. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90071-5 · Cited by 324
Self-citationDose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method
Leucht, S., Samara, M., Heres, S., Patel, M. X., Furukawa, T., Cipriani, A., Geddes, J., & Davis, J. M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv037 · Cited by 318
Self-citationAntipsychotic Drugs: A New Risk Factor for Osteoporosis in Young Women With Schizophrenia?
O'Keane, V., & Meaney, A. M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150223.31007.e0 · Cited by 307
Antipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208
REY, M.-J., SCHULZ, P., COSTA, C., DICK, P., & TISSOT, R. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00001 · Cited by 190
Casey, J. F. (1960) · A M A Archives of General Psychiatry · doi:10.1001/archpsyc.1960.03590080086012 · Cited by 140
Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?
Rijcken, C. A. W., Monster, T. B. M., Brouwers, J. R. B. J., & den Berg, L. T. W. D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000096247.29231.3a · Cited by 121
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Uchida, H., Suzuki, T., Takeuchi, H., Arenovich, T., & Mamo, D. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp149 · Cited by 105
How to compare doses of different antipsychotics: A systematic review of methods
Patel, M. X., Arista, I. A., Taylor, M., & Barnes, T. R. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.06.030 · Cited by 96
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
Nosè, M., Tansella, M., Thornicroft, G., Schene, A. H., Becker, T. M., Veronese, A., Leese, M., Koeter, M. W. J., Angermeyer, M. C., & Barbui, C. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328303ac75 · Cited by 83
Sweileh, W. M., Odeh, J. B., Shraim, N. Y., Zyoud, S. H., Sawalha, A. F., & Al‐Jabi, S. W. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.03.003 · Cited by 35
Xiang, Y., Weng, Y.-Z., Leung, C. M., Tang, W. K., & Ungvari, G. S. (2008) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46245 · Cited by 23
Cited by
Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia
Leucht, S., Crippa, A., Siafis, S., Patel, M. X., Orsini, N., & Davis, J. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010034 · Cited by 301
Self-citationIllusory generalizability of clinical prediction models
Chekroud, A. M., Hawrilenko, M., Loho, H., Bondar, J., Gueorguieva, R., Hasan, A., Kambeitz, J., Corlett, P. R., Koutsouleris, N., Krumholz, H. M., et al. (2024) · Science · doi:10.1126/science.adg8538 · Cited by 251
Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14122-0 · Cited by 243
Carbon, M., Kane, J. M., Leucht, S., & Correll, C. U. (2018) · World Psychiatry · doi:10.1002/wps.20579 · Cited by 214
Enhanced predictive signalling in schizophrenia
Schmack, K., Rothkirch, M., Priller, J., & Sterzer, P. (2017) · Human Brain Mapping · doi:10.1002/hbm.23480 · Cited by 81
Metadata
- Authors
- Leucht, S., Samara, M., Heres, S., & Davis, J. M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07
- Volume
- 42
- Issue
- suppl 1
- Pages
- S90-S94
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2507950479
- Cited by
- 762
- References
- 20
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.